Selective immunosuppression by drugs in balanced immune responses.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D002455:Cell Division; D002999:Clone Cells; D003561:Cytarabine / Q000494:pharmacology; D003601:Cytotoxicity Tests, Immunologic; D005472:Fluorouracil / Q000494:pharmacology; D006084:Graft Rejection; D006462:Hemolytic Plaque Technique; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008214:Lymphocytes / Q000276:immunology; D008325:Mammary Neoplasms, Experimental / Q000276:immunology; D008727:Methotrexate / Q000494:pharmacology; D051379:Mice; D008805:Mice, Inbred A; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D009368:Neoplasm Transplantation; D016038:Skin Transplantation; D013154:Spleen / Q000276:immunology; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D003561:Cytarabine; D005472:Fluorouracil; D008727:Methotrexate